Researchers have developed a method that could drastically accelerate the search for new drugs to treat mental health disorders such as schizophrenia.
Improvements in public health, education and medicine mean that our lives are much longer than at any point in human history. Thanks to studies of volunteers from the eastern region, we may be able to spend these extra years living independently and in good health.
Today, on International Women's Day, we celebrate the achievements of women, raise awareness against bias and take action for equality.
The University of Cambridge has received new government and industrial funding to support at least 350 PhD students over the next eight years, via the creation of new Centres for Doctoral Training (CDTs).
Researchers have developed a three-dimensional ‘organ on a chip’ which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research.
From their base halfway across the globe in Singapore, Cambridge researchers are working with colleagues from around the world to reduce carbon emissions in industry.
An international team of researchers have developed a low-cost sensor made from semiconducting plastic that can be used to diagnose or monitor a wide range of health conditions, such as surgical complications or neurodegenerative diseases.
Professor Lynn Gladden CBE, FRS, FREng has been selected to be the next Executive Chair of the Engineering and Physical Sciences Research Council (EPSRC), as announced today by Science Minister Sam Gyimah. She will take up the role in October, succeeding Professor Philip Nelson who will step down at the end of September.
A new home for the Department of Chemical Engineering and Biotechnology on the University’s West Cambridge site was formally opened today by the University Chancellor, The Lord Sainsbury of Turville.
Researchers from the UK and Denmark have developed a new method to predict the physical stability of drug candidates, which could help with the development of new and more effective medicines for patients. The technology has been licensed to Cambridge spin-out company TeraView, who are developing it for use in the pharmaceutical industry in order to make medicines that are more easily released in the body.
© 2025 University of Cambridge